Skip to main content
Clinical Trials

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer (CTMS# 19-0019)

Cancer Type

Urothelial Tract/Bladder Cancer

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Chethan Ramamurthy M.D.

For more information about this study
View Details

About This Study